Cargando…
Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort
BACKGROUND: Long‐term population‐representative data on motor fluctuations and levodopa‐induced dyskinesias in Parkinson's disease is lacking. METHODS: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases followed for up to 13 years...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063985/ https://www.ncbi.nlm.nih.gov/pubmed/31965629 http://dx.doi.org/10.1002/mds.27882 |
_version_ | 1783504794482114560 |
---|---|
author | Kim, Han‐Joon Mason, Sarah Foltynie, Thomas Winder‐Rhodes, Sophie Barker, Roger A. Williams‐Gray, Caroline H. |
author_facet | Kim, Han‐Joon Mason, Sarah Foltynie, Thomas Winder‐Rhodes, Sophie Barker, Roger A. Williams‐Gray, Caroline H. |
author_sort | Kim, Han‐Joon |
collection | PubMed |
description | BACKGROUND: Long‐term population‐representative data on motor fluctuations and levodopa‐induced dyskinesias in Parkinson's disease is lacking. METHODS: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases followed for up to 13 years (n = 141). Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias and risk factors were assessed using Kaplan‐Meyer and Cox regression analyses. RESULTS: Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias was 54.3% and 14.5%, respectively, at 5 years and 100% and 55.7%, respectively, at 10 years. Higher baseline UPDRS‐total and SNCA rs356219(A) predicted motor fluctuations, whereas higher baseline Mini‐mental State Examination and GBA mutations predicted levodopa‐induced dyskinesias. Early levodopa use did not predict motor complications. Both early motor fluctuations and levodopa‐induced dyskinesias predicted reduced mortality in older patients (age at diagnosis >70 years). CONCLUSIONS: Our data support the hypothesis that motor complications are related to the severity of nigrostriatal pathology rather than early levodopa use and indicate that early motor complications do not necessarily confer a negative prognosis. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. |
format | Online Article Text |
id | pubmed-7063985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70639852020-03-16 Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort Kim, Han‐Joon Mason, Sarah Foltynie, Thomas Winder‐Rhodes, Sophie Barker, Roger A. Williams‐Gray, Caroline H. Mov Disord Brief Reports BACKGROUND: Long‐term population‐representative data on motor fluctuations and levodopa‐induced dyskinesias in Parkinson's disease is lacking. METHODS: The Cambridgeshire Parkinson's Incidence from GP to Neurologist (CamPaIGN) cohort comprises incident PD cases followed for up to 13 years (n = 141). Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias and risk factors were assessed using Kaplan‐Meyer and Cox regression analyses. RESULTS: Cumulative incidence of motor fluctuations and levodopa‐induced dyskinesias was 54.3% and 14.5%, respectively, at 5 years and 100% and 55.7%, respectively, at 10 years. Higher baseline UPDRS‐total and SNCA rs356219(A) predicted motor fluctuations, whereas higher baseline Mini‐mental State Examination and GBA mutations predicted levodopa‐induced dyskinesias. Early levodopa use did not predict motor complications. Both early motor fluctuations and levodopa‐induced dyskinesias predicted reduced mortality in older patients (age at diagnosis >70 years). CONCLUSIONS: Our data support the hypothesis that motor complications are related to the severity of nigrostriatal pathology rather than early levodopa use and indicate that early motor complications do not necessarily confer a negative prognosis. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. John Wiley & Sons, Inc. 2019-11-11 2020-01 /pmc/articles/PMC7063985/ /pubmed/31965629 http://dx.doi.org/10.1002/mds.27882 Text en © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Reports Kim, Han‐Joon Mason, Sarah Foltynie, Thomas Winder‐Rhodes, Sophie Barker, Roger A. Williams‐Gray, Caroline H. Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort |
title | Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort |
title_full | Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort |
title_fullStr | Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort |
title_full_unstemmed | Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort |
title_short | Motor complications in Parkinson's disease: 13‐year follow‐up of the CamPaIGN cohort |
title_sort | motor complications in parkinson's disease: 13‐year follow‐up of the campaign cohort |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063985/ https://www.ncbi.nlm.nih.gov/pubmed/31965629 http://dx.doi.org/10.1002/mds.27882 |
work_keys_str_mv | AT kimhanjoon motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort AT masonsarah motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort AT foltyniethomas motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort AT winderrhodessophie motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort AT barkerrogera motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort AT williamsgraycarolineh motorcomplicationsinparkinsonsdisease13yearfollowupofthecampaigncohort |